Literature DB >> 1902340

Effects of CO2 and N2 partial pressures on cognitive and psychomotor performance.

D M Fothergill1, D Hedges, J B Morrison.   

Abstract

This study examined N2 and CO2 components of narcosis by comparing the effects of three levels of PETCO2 [low = 29 mmHg (SD = 4 mmHg), medium = 47 mmHg (SD = 1 mmHg), high = 57 mmHg (SD = 2 mmHg)] at 1 and 6 atm abs in 12 male volunteers. Cognitive and psychomotor performances were examined using a variety of tasks, including a modified Stroop test, an arithmetic test, number comparison, a figure copying test, and the Purdue pegboard test. Performance on all tasks demonstrated significant (P less than 0.05) decrements at 6 atm abs. High CO2 tensions significantly impaired cognitive and psychomotor performance at 1 atm abs and caused further decrements at 6 atm abs (P less than 0.05). However, no significant N2-CO2 interaction (P greater than 0.05) or global threshold for the onset of CO2 narcosis was indicated by the test scores. The pattern of intratest results were different for N2 and CO2. At high PETCO2, performance deficits were due to a slowing of performance rather than a disruption of the accuracy of processing. Nitrogen narcosis, conversely, produced significant impairment through both decreases in the speed and accuracy of processing on the majority of performance tests. It was concluded that within the PETCO2 ranges studied: a) PETCO2 and PIN2 are additive in their effects on impaired cognitive and psychomotor performance at depth; b) high PETCO2 and PIN2 induce distinctly different strategic responses on the speed accuracy trade-off function of the performance tests; c) decrements in cognitive and psychomotor performance under high PETCO2 do not conform to the predicted narcotic potency of CO2 according to the lipid solubility theory of narcosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902340

Source DB:  PubMed          Journal:  Undersea Biomed Res        ISSN: 0093-5387


  8 in total

1.  Ventilatory and integrated physiological responses to chronic hypercapnia in goats.

Authors:  Nicholas J Burgraff; Suzanne E Neumueller; Kirstyn Buchholz; Thomas M Langer; Matthew R Hodges; Lawrence Pan; Hubert V Forster
Journal:  J Physiol       Date:  2018-10-14       Impact factor: 5.182

Review 2.  Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?

Authors:  Kai Kisielinski; Paul Giboni; Andreas Prescher; Bernd Klosterhalfen; David Graessel; Stefan Funken; Oliver Kempski; Oliver Hirsch
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

Review 3.  Computerised cognitive assessment of athletes with sports related head injury.

Authors:  A Collie; D Darby; P Maruff
Journal:  Br J Sports Med       Date:  2001-10       Impact factor: 13.800

4.  Depression of cortical activity in humans by mild hypercapnia.

Authors:  Thomas Thesen; Oleg Leontiev; Tao Song; Nima Dehghani; Donald J Hagler; Mingxiong Huang; Richard Buxton; Eric Halgren
Journal:  Hum Brain Mapp       Date:  2011-04-15       Impact factor: 5.038

5.  Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic sleep disordered breathing patients.

Authors:  David Wang; Amanda J Piper; Brendon J Yee; Keith K Wong; Jong-Won Kim; Angela D'Rozario; Luke Rowsell; Derk-Jan Dijk; Ronald R Grunstein
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

Review 6.  Anxiety and panic in recreational scuba divers.

Authors:  W P Morgan
Journal:  Sports Med       Date:  1995-12       Impact factor: 11.136

7.  Moving in extreme environments: inert gas narcosis and underwater activities.

Authors:  James E Clark
Journal:  Extrem Physiol Med       Date:  2015-02-24

8.  Contribution of hypercapnia to cognitive impairment in severe sleep-disordered breathing.

Authors:  Andrew E Beaudin; Jill K Raneri; Najib T Ayas; Robert P Skomro; Eric E Smith; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.